{Reference Type}: Journal Article
{Title}: Optochemical control of slow-wave sleep in the nucleus accumbens of male mice by a photoactivatable allosteric modulator of adenosine A2A receptors.
{Author}: Roy K;Zhou X;Otani R;Yuan PC;Ioka S;Vogt KE;Kondo T;Farag NHT;Ijiri H;Wu Z;Chitose Y;Amezawa M;Uygun DS;Cherasse Y;Nagase H;Li Y;Yanagisawa M;Abe M;Basheer R;Wang YQ;Saitoh T;Lazarus M;
{Journal}: Nat Commun
{Volume}: 15
{Issue}: 1
{Year}: 2024 Apr 30
{Factor}: 17.694
{DOI}: 10.1038/s41467-024-47964-4
{Abstract}: Optochemistry, an emerging pharmacologic approach in which light is used to selectively activate or deactivate molecules, has the potential to alleviate symptoms, cure diseases, and improve quality of life while preventing uncontrolled drug effects. The development of in-vivo applications for optochemistry to render brain cells photoresponsive without relying on genetic engineering has been progressing slowly. The nucleus accumbens (NAc) is a region for the regulation of slow-wave sleep (SWS) through the integration of motivational stimuli. Adenosine emerges as a promising candidate molecule for activating indirect pathway neurons of the NAc expressing adenosine A2A receptors (A2ARs) to induce SWS. Here, we developed a brain-permeable positive allosteric modulator of A2ARs (A2AR PAM) that can be rapidly photoactivated with visible light (λ > 400 nm) and used it optoallosterically to induce SWS in the NAc of freely behaving male mice by increasing the activity of extracellular adenosine derived from astrocytic and neuronal activity.